Brigit High1, Alison M Hixon1, Kenneth L Tyler1, Amanda L Piquet1, Victoria S Pelak1. 1. Medical Scientist Training Program (BH, AMH), Rocky Mountain Taste and Smell Center (BH), Department of Neurology (KLT, ALP, VSP), and Department of Ophthalmology (VSP), University of Colorado School of Medicine, Aurora.
Abstract
PURPOSE OF REVIEW: The current coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is one of the greatest medical crises faced by our current generation of health care providers. Although much remains to be learned about the pathophysiology of SARS-CoV-2, there is both historical precedent from other coronaviruses and a growing number of case reports and series that point to neurologic consequences of COVID-19. RECENT FINDINGS: Olfactory/taste disturbances and increased risk of strokes and encephalopathies have emerged as potential consequences of COVID-19 infection. Evidence regarding whether these sequelae result indirectly from systemic infection or directly from neuroinvasion by SARS-CoV-2 is emerging. SUMMARY: This review summarizes the current understanding of SARS-CoV-2 placed in context with our knowledge of other human coronaviruses. Evidence and data regarding neurologic sequelae of COVID-19 and the neuroinvasive potential of human coronaviruses are provided along with a summary of patient registries of interest to the Neurology community.
PURPOSE OF REVIEW: The current coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is one of the greatest medical crises faced by our current generation of health care providers. Although much remains to be learned about the pathophysiology of SARS-CoV-2, there is both historical precedent from other coronaviruses and a growing number of case reports and series that point to neurologic consequences of COVID-19. RECENT FINDINGS: Olfactory/taste disturbances and increased risk of strokes and encephalopathies have emerged as potential consequences of COVID-19 infection. Evidence regarding whether these sequelae result indirectly from systemic infection or directly from neuroinvasion by SARS-CoV-2 is emerging. SUMMARY: This review summarizes the current understanding of SARS-CoV-2 placed in context with our knowledge of other human coronaviruses. Evidence and data regarding neurologic sequelae of COVID-19 and the neuroinvasive potential of human coronaviruses are provided along with a summary of patient registries of interest to the Neurology community.
Authors: Daniel Wrapp; Nianshuang Wang; Kizzmekia S Corbett; Jory A Goldsmith; Ching-Lin Hsieh; Olubukola Abiona; Barney S Graham; Jason S McLellan Journal: Science Date: 2020-02-19 Impact factor: 47.728
Authors: Emily C W Hung; Stephen S C Chim; Paul K S Chan; Yu K Tong; Enders K O Ng; Rossa W K Chiu; Chi-Bon Leung; Joseph J Y Sung; John S Tam; Y M Dennis Lo Journal: Clin Chem Date: 2003-12 Impact factor: 8.327
Authors: Amber Salter; Robert J Fox; Scott D Newsome; June Halper; David K B Li; Pamela Kanellis; Kathleen Costello; Bruce Bebo; Kottil Rammohan; Gary R Cutter; Anne H Cross Journal: JAMA Neurol Date: 2021-06-01 Impact factor: 18.302
Authors: Martina Capponi; Bianca Laura Cinicola; Giulia Brindisi; Cristiana Alessia Guido; Maria Cristina Torcé; Anna Maria Zicari; Alberto Spalice Journal: Ital J Pediatr Date: 2022-06-18 Impact factor: 3.288